Dr Kamalnayan Gupta

  • Clinical Oncologist
  • Spoken languages English


Special clinical interest in prostate, colon, rectum, bladder, bowel, kidney, urological, & colorectal cancers

In 1999, Dr Gupta qualified in medicine and surgery and was awarded the MBBS Gold Medal. After a meritorious selection, he completed the MD programme in Oncology. He went on to obtain the Diplomate of National Boards in Clinical Oncology and was admitted as a Member of National Academy of Medical Sciences. Dr Gupta then obtained MRCP and proceeded to complete higher specialist training in Clinical Oncology at the Christie Hospital in Manchester and obtained FRCR. He was awarded the Royal College of Radiologists’ Award and completed the Proton Therapy Fellowship at the MD Anderson Cancer Centre in Texas, USA.

As a Consultant Clinical Oncologist, Dr Gupta works at the Northampton General Hospital & Kettering General Hospitals and additionally, Dr Gupta provides services at the BMI Three Shires Hospital in Northampton, Spire South Bank Hospital in Worcester and the GenesisCare Centre in Milton Keynes.

Dr Gupta has a special interest in urological cancers including prostate, bladder, kidney and ureter cancers and lower GI cancers (including rectum and colon cancers) and has expertise in all standard and advanced radiotherapy techniques (including IMRT, IGRT, and brachytherapy) as well as in all types of systemic therapies, including chemotherapy, immunotherapy, and novel agents for all urological and colorectal cancers.

Dr Gupta is the regional lead for prostate brachytherapy and maintains a research portfolio via involvement in multiple clinical trials in both Principal & Co-Investigator roles.

Dr Gupta is the regional Educational Lead and Clinical Audit Lead and is ASCO’s UK representative for the ASCO Learning Cohort and Educational Committee.

Dr Gupta has spoken at various national and international conferences and meetings.


Intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), brachytherapy and all types of systemic therapies including chemotherapy, immunotherapy, and use of novel agents


  • Colon
  • Lower gastrointestinal (GI) cancers
  • Urology

NHS Hospital / current post(s)

  • Consultant Clinical Oncologist, Northampton General Hospital and
  • Kettering General Hospital

Clinical interests

Prostate cancer, colon cancer, rectum cancer, radiotherapy, chemotherapy, immunotherapy, hormone therapy, bladder cancer, bowel cancer, kidney cancer, urological cancers, colorectal cancers, brachytherapy

Professional memberships

Fellow of the Royal College of Radiotherapy (FRCR), Member of the Royal College of Physicians (MRCP)

Awards received

Royal College of Radiologists’ Award